Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Cytosorbents Corporation (CTSO)

Compare
1.0100
+0.0200
+(2.02%)
At close: April 15 at 4:00:01 PM EDT
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
47,371.5000
52,956.3220
63,231.5300
89,519.2820
Total Liabilities Net Minority Interest
36,264.5640
29,475.1080
27,856.5570
26,941.0850
Total Equity Gross Minority Interest
11,106.9360
23,481.2140
35,374.9730
62,578.1970
Total Capitalization
25,103.2860
26,024.0710
40,374.9730
62,578.1970
Common Stock Equity
11,106.9360
23,481.2140
35,374.9730
62,578.1970
Capital Lease Obligations
12,896.6590
13,270.2950
13,250.9440
13,821.5090
Net Tangible Assets
7,358.9000
19,574.6620
30,984.4400
57,876.2130
Working Capital
11,778.9990
11,362.9190
24,045.1390
50,608.7480
Invested Capital
25,103.2860
28,524.0710
40,374.9730
62,578.1970
Tangible Book Value
7,358.9000
19,574.6620
30,984.4400
57,876.2130
Total Debt
26,893.0090
18,313.1520
18,250.9440
13,821.5090
Net Debt
10,716.4240
--
--
--
Share Issued
60,929.5690
54,510.1170
43,852.8080
43,694.7970
Ordinary Shares Number
60,929.5690
54,510.1170
43,852.8080
43,694.7970
12/31/2021 - 8/8/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers